MarketInOut Stock Screener Log In | Sign Up
 

Amphastar Pharmaceuticals Inc

NASDAQ • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 06/24/2026 16:00
Amphastar Pharmaceuticals Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization808.22 mln
Float32.82 mln
Earnings Date08/10/2026

EPS

1.66
Decent

P / E

12.66
Fair value

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.72
Likely reliable

1-Year Forecast

22.83
Modest upside

Relative Strength

79 / 100
Strongly outperforming

Business Description

Amphastar Pharmaceuticals is a drug maker based in Rancho Cucamonga, California, operating across the United States, China, and France since 1996. The company produces and sells a broad range of injectable, inhaled, and nasal medicines, covering both branded and generic treatments for conditions such as severe low blood sugar, asthma, opioid overdose, blood clots, and osteoporosis, among others. Amphastar also supplies raw pharmaceutical ingredients, including insulin, to support broader drug manufacturing needs.

Key Fundamentals

EPS1.66
P/E12.66
ROE10.30
RPS15.21
ROIC7.49
ROA4.84
Interest Cover4.53
EBITDA, mln193
EV / EBITDA6.35
EV / EBIT9.53
Revenue, mln721
EV / Revenue1.70

Financial Strength

Altman Z-Score2.18
Piotroski F-Score 6 / 9
Beneish M-Score-2.72
Price to Intrinsic Value0.40
Price to Lynch Fair Value0.34
Price to Graham Number1.20
1-Year Target Price22.83
Shiller PE Ratio13.89
Short Ratio4.91
Short % of Float17.78

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 5.31% 88 / 100   
1 Month 14.18% 90 / 100   
2 Months 7.74% 65 / 100   
6 Months -20.98% 23 / 100   
1 Year -14.83% 26 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us